An Open-Label Randomized Clinical Trial to Evaluate the Efficacy and Safety of Short Course Antiretroviral Therapy for Acute or Recent HIV-1 Infection in Zimbabwe and the United States.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms COZI
- 20 Feb 2013 Biomarkers information updated
- 03 Apr 2012 Actual patient number is 16 as reported by ClinicalTrials.gov. (NCT00414518).
- 03 Apr 2012 Actual patient number is 16 as reported by ClinicalTrials.gov. (NCT00414518).